Search results
Fabrizio D'Abate
Job title: Clinical Vascular Scientist
Author
Sergey Kozhukhov
Research Area(s) / Expertise:
Job title: Director of the Cardio-Oncology Center and Head of Clinical Pharmacology and Cardio-Oncology Department
Author
Author(s):
Paul Roberts
,
Mohamed Hassan ElRefai
,
Paul Foley
,
et al
Added:
1 year ago
Author(s):
Rikke Esberg Kirkfeldt
,
Jens Brock Johansen
,
Jens Cosedis Nielsen
Added:
3 years ago
Cardiac implantable electronic device (CIED) therapy is effective and safe. However, infections related to CIED treatment may have devastating consequences, causing significant morbidity, mortality and generating considerable healthcare costs.1–6 Temporal trends in CIED treatment indicate a disproportional increase in CIED infections relative to implantation rates.1,7,8 Reasons for this trend are…
View more
Terumo Europe NV
Supplier
Author(s):
Sunil Kapur
,
Moussa Mansour
Added:
3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting more than three million Americans.1 The management of AF revolves around the alleviation of symptoms related to an accelerated and irregular ventricular response, and the prevention of cardioembolism, notably stroke. In patients with AF, there is a fivefold increased incidence of embolic stroke.2 The prevention of systemic…
View more
Jeff Healey
Author
Author(s):
Henry Chubb
,
Mark O’Neill
,
Eric Rosenthal
Added:
3 years ago
Device therapy is increasingly employed in the management of complex congenital heart disease (CHD). Bradycardias, most often related to sinus nodal dysfunction (SND) or atrioventricular nodal (AVN) block, may necessitate the implantation of pacing devices, while malignant arrhythmias may be treated by appropriate use of implantable cardioverter defibrillators (ICDs). However, there is a complex…
View more
Author(s):
Baldeep S Sidhu
,
Justin Gould
,
Mark Elliott
,
et al
Added:
2 years ago
TCT 23: WATCH-TAVR
Author(s):
Samir R Kapadia
Added:
4 months ago
Video